Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

M
M. Pereira, Patricia

Instituto Português de Oncologia de Lisboa Francisco Gentil
(P 372) CLINICOPATHOLOGICAL FEATURES AND OUTCOMES OF PATIENTS WITH KAPOSI SARCOMA: A SINGLE CENTER RETROSPECTIVE REAL WORLD ANALYSIS
Patricia M. Pereira
Favorite
Mørk Petersen, Michael

Department of orthopedic surgery, Copenhagen University Hospital, Denmark
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Michael Mørk Petersen
Favorite
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Michael Mørk Petersen
Favorite
Maccaroni, Elena

Department of Oncology, Azienda Ospedaliero-Universitaria delle Marche
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Elena Maccaroni
Favorite
MacDonald, Shannon

Southwest Florida Proton
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Shannon MacDonald
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Shannon MacDonald
Favorite
MacGregor, Peter

Huntsman Cancer Institute
(P 01) FEASIBILITY OF A QUANTITATIVE METHYLATION-BASED CTDNA ASSAY IN PATIENTS WITH ADVANCED SARCOMAS
Peter MacGregor
Favorite
Macierzynski, Agnieszka

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Agnieszka Macierzynski
Favorite
Mackert, Gina

Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, 67071 Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Gina Mackert
Favorite
Mack, Jennifer

Dana-Farber Cancer Institute
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Jennifer Mack
Favorite
Mack, Lloyd

Arthur Child Cancer Center/ University of Calgary
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Lloyd Mack
Favorite
MacQuarrie, Kyle

Northwestern University Feinberg School of Medicine/Ann & Robert H Lurie Children's Hospital of Chicago
(P 252) NUCLEAR AND GENOMIC ORGANIZATION OF CHEMOTHERAPY RESISTANT RHABDOMYOSARCOMA CELLS
Kyle MacQuarrie
Favorite
Madewell, John E.

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
John E. Madewell
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
John E. Madewell
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
John E. Madewell
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
John E. Madewell
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
John E. Madewell
Favorite
Madison, Cecelia

VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Cecelia Madison
Favorite
Ma, dongyang

Department of Anesthesiology, Peking University International Hospital
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
dongyang Ma
Favorite
Magagnoli, Giovanna

IRCCS Istituto Ortopedico Rizzoli
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Giovanna Magagnoli
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Giovanna Magagnoli
Favorite
Maganti, Manjula

Princess Margaret Cancer Centre
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Manjula Maganti
Favorite
MAGNAN, MARIE CLAUDE

University of Toronto
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
MARIE CLAUDE MAGNAN
Favorite
Magnelli, Anthony

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Anthony Magnelli
Favorite
Magrath, Justin

Tulane University
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Justin Magrath
Favorite
Maheshwari, Aryan

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Aryan Maheshwari
Favorite
Mahoney, Douglas

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Douglas Mahoney
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Douglas Mahoney
Favorite
Mai Nørbak, Malene

Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Malene Mai Nørbak
Favorite
Mailhot, Anne

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Anne Mailhot
Favorite
Maioli, Margherita

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Margherita Maioli
Favorite
Majercakova, Katarina

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Katarina Majercakova
Favorite
MAKI, Robert

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Robert MAKI
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Robert MAKI
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Robert MAKI
Favorite
Makuła, Donata

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Donata Makuła
Favorite
Malchau, Erik

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Erik Malchau
Favorite
Maleddu, Alessandra

Department of Medicine, University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Alessandra Maleddu
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Alessandra Maleddu
Favorite
Malinowska, Natalia

Maria Sklodowska-Curie National Research Institute of Oncology
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Natalia Malinowska
Favorite
Malinowski, Alexandra

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Alexandra Malinowski
Favorite
Malkin, David

The Hospital for Sick Children
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
David Malkin
Favorite
Malli, Shashwath Kalladi

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Shashwath Kalladi Malli
Favorite
Malogolowkin, Marcio

University of California, Davis
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Marcio Malogolowkin
Favorite
Mamede, Isadora

Federal University of São João del Rei, Divinópolis, Brazil
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Isadora Mamede
Favorite
Manalo, Zoe

University of Miami
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Zoe Manalo
Favorite
Mandel, Gabriel

Cleveland Clinic
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Gabriel Mandel
Favorite
Mangla, Ankit

Case Comprehensive Cancer Center
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Ankit Mangla
Favorite
Mangray, Shamlal

Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Shamlal Mangray
Favorite
Manion, Elizabeth

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Elizabeth Manion
Favorite
Manish, Agarwal

Nanavati Max Super Speciality Hospital / Hinduja Hospital
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Agarwal Manish
Favorite
Manjali, Jifmi

Tata Memorial Hospital
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Jifmi Manjali
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Jifmi Manjali
Favorite
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Jifmi Manjali
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Jifmi Manjali
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Jifmi Manjali
Favorite
Mann, Gary

Roswell Park Comprehensive Cancer Center
(P 340) PREDICTORS OF LATE RECURRENCE AFTER SARCOMA SURGICAL RESECTION
Gary Mann
Favorite
Manzano, Aranzazu

HOSPITAL CLINIO SAN CARLOS
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
Aranzazu Manzano
Favorite
Mao, Jie

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Jie Mao
Favorite
Maoz, Myriam

Oncology Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Myriam Maoz
Favorite
Maple, Ellen

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Ellen Maple
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Ellen Maple
Favorite
Mar, Damon

University of Kansas School of Medicine
(P 359) EVALUATION OF PREOPERATIVE MYXOFIBROSARCOMA GROWTH AND SURGICAL MORBIDITY AFTER NEOADJUVANT RADIATION USING SEMI-AUTOMATED VOLUMETRIC ANALYSIS
Damon Mar
Favorite
(P 382) METHOD FOR VOLUMETRIC ASSESMENT OF TUMOR RESPONSE FOLLOWING NEOADJUVANT RADIATION IN PRIMARY MYXOFIBROSARCOMA
Damon Mar
Favorite
Mariuk-Jarema, Ann

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Ann Mariuk-Jarema
Favorite
Marquez-Gaffaro, Gloria

Hospital Universitario Fundación Jiménez Díaz
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Gloria Marquez-Gaffaro
Favorite
Marquez, John Patrick

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
John Patrick Marquez
Favorite
(P 399) LATE LOCAL RECURRENCE (>5YEARS) OF SOFT TISSUE SARCOMA OF THE EXTREMITIES AND TRUNK WALL: PREDICTIVE FACTORS AND ONCOLOGIC OUTCOMES
John Patrick Marquez
Favorite
Marquina-Ospina, Gloria

Hospital Clinico San Carlos. Department of Medical Oncology
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Gloria Marquina-Ospina
Favorite
Marritt, Kayla

University of Saskatchewan
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Kayla Marritt
Favorite
Martín-Broto, Javier

Fundación Jiménez Díaz University Hospital
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Javier Martín-Broto
Favorite
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Javier Martín-Broto
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Javier Martín-Broto
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Javier Martín-Broto
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Javier Martín-Broto
Favorite
Martin, Camino Ruano San

A*STAR Bioinformatics Institute (BII)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Camino Ruano San Martin
Favorite
Martin, Dana

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Dana Martin
Favorite
Martínez-Bernal, Gala

Hospital Universitario Virgen del Rocio
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
Gala Martínez-Bernal
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
Gala Martínez-Bernal
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Gala Martínez-Bernal
Favorite
Martinez, Daniel

1.University of Miami , Miller School of Medicine, Department of Orthopedic Surgery
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
Daniel Martinez
Favorite
Martinez-Garcia, Jeronimo

Hospital Universitario Virgen de la Arrixaca
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Jeronimo Martinez-Garcia
Favorite
Martinez, Jeronimo

Hospital Universitario Virgen de la Arrixaca
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Jeronimo Martinez
Favorite
Martinez-Trufero, Javier

Hospital Universitario Miguel Servet
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Javier Martinez-Trufero
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Javier Martinez-Trufero
Favorite
Martin, John

Rush University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
John Martin
Favorite
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
John Martin
Favorite
Martin, Olivia

Roswell Park Comprehensive Cancer Center
(P 340) PREDICTORS OF LATE RECURRENCE AFTER SARCOMA SURGICAL RESECTION
Olivia Martin
Favorite
Martinuzzi, Arianna

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Arianna Martinuzzi
Favorite
Marwa, Billal

Division of Medical Oncology, Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Billal Marwa
Favorite
Mascarenhas, Leo

Cedars-Sinai Medical Center
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Leo Mascarenhas
Favorite
Mascherini, Matteo

IRCCS Ospedale Policlinico San Martino
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Matteo Mascherini
Favorite
Massa, Giacomo

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Giacomo Massa
Favorite
Matarangas, Ariana

Duke University
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Ariana Matarangas
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Ariana Matarangas
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Ariana Matarangas
Favorite
Matin, Bahar

Clinical Pharmacology, IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Bahar Matin
Favorite
Matsumoto, Koji

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Koji Matsumoto
Favorite
Mattei, Jean Camille

APHM and Hôpital Européen Marseille
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Jean Camille Mattei
Favorite
Matyas, John

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
John Matyas
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
John Matyas
Favorite
Mauguen, Audrey

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Audrey Mauguen
Favorite
Ma, Xinyi

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Xinyi Ma
Favorite
Ma, Yan

Duke University Medical Center
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Yan Ma
Favorite
May, Dalit

Shaare Zedek Medical Center
(P 326) GERMLINE POT1 MUTATIONS IN ANGIOSARCOMA DIFFER FROM SOMATIC MUTATIONS
Dalit May
Favorite
Mayerson, Joel

Ohio State University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Joel Mayerson
Favorite
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
Joel Mayerson
Favorite
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Joel Mayerson
Favorite
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Joel Mayerson
Favorite
Mazcko, Christina

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Christina Mazcko
Favorite
Mazzocca, Alessandro

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Alessandro Mazzocca
Favorite
Mazzocca, Alessandro

UNIVERSITA' CAMPUS BIO-MEDICO ROMA
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Alessandro Mazzocca
Favorite
Mazzocca, Alessandro

Fondazione Policlinico Universitario Campus Bio-Medico
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Alessandro Mazzocca
Favorite
McAlearney, Ann

The Ohio State University
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Ann McAlearney
Favorite
McAlpine, Cheryl

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Cheryl McAlpine
Favorite
Mcavoy, Devin

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Devin Mcavoy
Favorite
McCaw, Nicole

University of Colorado School of Medicine
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Nicole McCaw
Favorite
McCutcheon, Ian

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Ian McCutcheon
Favorite
McEachron, Troy

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Troy McEachron
Favorite
McFadden, Andrew

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Andrew McFadden
Favorite
McGee, Lauren

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Lauren McGee
Favorite
McGough, Richard

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Richard McGough
Favorite
McKenzie, Laurie

University of Texas MD Anderson Cancer Center
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Laurie McKenzie
Favorite
McKinney, Caleb

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Caleb McKinney
Favorite
McManus, Jeanine

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Jeanine McManus
Favorite
Meade, Julia

UPMC Children’s Hospital of Pittsburgh
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Julia Meade
Favorite
Mebrahtu, Aron

Duke University School of Medicine
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Aron Mebrahtu
Favorite
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Aron Mebrahtu
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Aron Mebrahtu
Favorite
Meijer, Debora

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Debora Meijer
Favorite
Melendez-Fernandez, Ana

National Cancer Institute Mexico
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Ana Melendez-Fernandez
Favorite
Melissa, Gosdin

University of California Davis School of Medicine
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Gosdin Melissa
Favorite
Mendez-Gomez, Hector

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Hector Mendez-Gomez
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Hector Mendez-Gomez
Favorite
Mendez-Pino, Eduardo

Mass General Brigham
(P 87) ACUTE PATHOLOGICAL LONG BONE FRACTURES: WEEKEND VERSUS WEEKDAY VARIATIONS AND THEIR CLINICAL IMPACT
Eduardo Mendez-Pino
Favorite
Menge, Franka

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Franka Menge
Favorite
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Franka Menge
Favorite
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Franka Menge
Favorite
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Franka Menge
Favorite
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Franka Menge
Favorite
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Franka Menge
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Franka Menge
Favorite
Menzies, Alexander

Melanoma Institute Australia, The University of Sydney
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Alexander Menzies
Favorite
Mercatali, Laura

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Laura Mercatali
Favorite
Merchant, Nipun

University of Miami Hospital, Department of Surgical Oncology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Nipun Merchant
Favorite
Merks, Johannes

University Medical Center Utrecht
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Johannes Merks
Favorite
Merlini, Alessandra

University Hospital S. Luigi Gonzaga
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Alessandra Merlini
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Alessandra Merlini
Favorite
Merriam, Priscilla

Dana-Farber Cancer Institute
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Priscilla Merriam
Favorite
Merrill, Morgan

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Morgan Merrill
Favorite
Merritt, Ainsley

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Ainsley Merritt
Favorite
Mesko, Nathan

Cleveland Clinic
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Nathan Mesko
Favorite
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Nathan Mesko
Favorite
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Nathan Mesko
Favorite
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Nathan Mesko
Favorite
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Nathan Mesko
Favorite
(P 345) SARCOMA BIOPSY COMPARISON BETWEEN REFERRAL CENTERS AND TREATING CENTERS: THE MUSCULOSKELETAL TUMOR REGISTRY (MSTR) EXPERIENCE
Nathan Mesko
Favorite
(P 355) CLASSIFYING WOUND HEALING COMPLICATIONS IN SURGICALLY TREATED EXTREMITY SOFT TISSUE SARCOMA
Nathan Mesko
Favorite
MESQUIDA LUQUE, NEUS

HOSPITAL SON LLATZER
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
NEUS MESQUIDA LUQUE
Favorite
Messina, Maiya-Mari

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Maiya-Mari Messina
Favorite
Metts, Jonathan

Moffitt Cancer Center
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Jonathan Metts
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Jonathan Metts
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Jonathan Metts
Favorite
Meyer, Anders

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Anders Meyer
Favorite
Meza-Zepeda, Leonardo

Oslo University Hospital
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Leonardo Meza-Zepeda
Favorite
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Leonardo Meza-Zepeda
Favorite
Miah, Aisha

The Royal Marsden Hospital
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Aisha Miah
Favorite
Miceli, Rosalba

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Rosalba Miceli
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Rosalba Miceli
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Rosalba Miceli
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Rosalba Miceli
Favorite
Michaeli, Orly

Hemato-Oncology Laboratory, Schneider Children's Medical Center of Israel, Petach Tikva, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Orly Michaeli
Favorite
Michael, Samer

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Samer Michael
Favorite
Michel, Marius

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Marius Michel
Favorite
Michel, Maurice Stephan

Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Maurice Stephan Michel
Favorite
Michelon, Isabella

Department of Medicine, Catholic University of Pelotas, Brazil
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Isabella Michelon
Favorite
Michlitsch, Jennifer

UCSF Benioff Children's Hospital
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Jennifer Michlitsch
Favorite
MICHOT, audrey

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
audrey MICHOT
Favorite
(P 390) USE OF DERMAL TEMPLATE FOR NERVE PROTECTION IN LIMB-SPARING SURGERY FOR SOFT TISSUE SARCOMAS: PRELIMINARY EXPERIENCE FROM INSTITUT BERGONIE
audrey MICHOT
Favorite
Midboe, Amanda

US Department of Veteran Affairs
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Amanda Midboe
Favorite
Milhem, Mohammed

University of Iowa
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Mohammed Milhem
Favorite
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Mohammed Milhem
Favorite
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
Mohammed Milhem
Favorite
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Mohammed Milhem
Favorite
Millan Catalan, Oliver

Instituto Nacional de Cancerologia
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Oliver Millan Catalan
Favorite
Miller, Benjamin

University of Iowa
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Benjamin Miller
Favorite
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Benjamin Miller
Favorite
(P 345) SARCOMA BIOPSY COMPARISON BETWEEN REFERRAL CENTERS AND TREATING CENTERS: THE MUSCULOSKELETAL TUMOR REGISTRY (MSTR) EXPERIENCE
Benjamin Miller
Favorite
Miller, Ira

Nationwide Children's Hospital
(P 23) DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA
Ira Miller
Favorite
Miller, Jade

Vanderbilt University
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Jade Miller
Favorite
Miloh, Roy
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Roy Miloh
Favorite
Minard-Colin, Veronique

Gustave Roussy
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Veronique Minard-Colin
Favorite
Miranda, Hernan

Instituto Traumatologico Teodoro Gebauer
(P 212) MISINFORMATION IN SARCOMA CONTENT ON SOCIAL MEDIA PLATFORMS
Hernan Miranda
Favorite
MIRAS RODRIGUEZ, ISABEL

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
ISABEL MIRAS RODRIGUEZ
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
ISABEL MIRAS RODRIGUEZ
Favorite
Mir, Olivier

Institut Gustave-Roussy, Villejuif, France
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Olivier Mir
Favorite
Mitchell, Duane

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Duane Mitchell
Favorite
Mitra, Amitava

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Amitava Mitra
Favorite
Mitra, Ramkrishna

Thomas Jefferson University
(P 35) MECHANISTIC AND TRANSCRIPTOMIC ANALYSES REVEAL MUTATION-SPECIFIC THERAPEUTIC RESPONSES IN DESMOID TUMOR CELLS TREATED WITH SORAFENIB AND NIROGACESTAT
Ramkrishna Mitra
Favorite
Miyamoto, Ryo

Princess Margaret Cancer Centre, UHN
(P 67) MULTIPLE MESENCHYMAL LINEAGES AS POTENTIAL CELL-OF-ORIGINS OF SMARCB1-DEFICIENT EPITHELIOID SARCOMA
Ryo Miyamoto
Favorite
Miyazaki, Bunpei

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Bunpei Miyazaki
Favorite
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Bunpei Miyazaki
Favorite
Mizusawa, Junki

Clinical Research Support Office, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Junki Mizusawa
Favorite
Mock, Andreas

LMU Munich
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Andreas Mock
Favorite
Moding, Everett

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Everett Moding
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Everett Moding
Favorite
Modi, Shivani

Jefferson Einstein Healthcare Network
(P 330) LEIOMYOSARCOMA IN THE REAL WORLD: RETROSPECTIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS AT A COMMUNITY ONCOLOGY CENTER IN SOUTH FLORIDA (MEMORIAL HEALTHCARE SYSTEM)
Shivani Modi
Favorite
(P 459) EPIDEMIOLOGICAL TRENDS, TREATMENT PATTERNS, AND SURVIVAL DISPARITIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: A SEER ANALYSIS, 2001-2020
Shivani Modi
Favorite
Mody, Rajen

University of Michigan
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Rajen Mody
Favorite
Moebius, Ulrich

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Ulrich Moebius
Favorite
Mogavero, Andrea

University Hospital S. Luigi Gonzaga
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Andrea Mogavero
Favorite
Mohamed Noor, Nur Fazlin

National Cancer Center Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Nur Fazlin Mohamed Noor
Favorite
Mohan Gollamudi, Venkata Rama

ACTREC, Tata Memorial Centre, Mumbai
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Venkata Rama Mohan Gollamudi
Favorite
Mohei, Hesham

University of Pennsylvania
(P 240) NEW INSIGHTS FROM SPATIOTEMPORALLY DEFINED TUMOR INDUCTIONS IN A NOVEL MOUSE MODEL OF SYNOVIAL SARCOMA
Hesham Mohei
Favorite
Mohler, David

Stanford University
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
David Mohler
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
David Mohler
Favorite
Molloy, Alan

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Alan Molloy
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Alan Molloy
Favorite
Moncho, Juliet

Massachusetts General Hospital
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Juliet Moncho
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Juliet Moncho
Favorite
Mondaza-Hernandez, Jose

Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Jose Mondaza-Hernandez
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Jose Mondaza-Hernandez
Favorite
Monga, Varun

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Varun Monga
Favorite
Monjazeb, Arta

Radiation Oncology, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Arta Monjazeb
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Arta Monjazeb
Favorite
Monjure, Tia

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Tia Monjure
Favorite
Monteleone, Laura

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Laura Monteleone
Favorite
Montgomery, Elizabeth Anne

University of Miami Miller School of Medicine
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Elizabeth Anne Montgomery
Favorite
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Elizabeth Anne Montgomery
Favorite
Montiel, Eduarda M. S.

AC Camargo Cancer Center
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Eduarda M. S. Montiel
Favorite
Montoya-Cerrillo, Diego

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Diego Montoya-Cerrillo
Favorite
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Diego Montoya-Cerrillo
Favorite
Monument, Michael

University of Calgary
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Michael Monument
Favorite
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Michael Monument
Favorite
(P 239) CHARACTERIZING THE ROLES OF T-CELLS IN THE CONTEXT OF TUMOR CLEARANCE AND MEMORY IN THE KP MODEL OF SARCOMA FOLLOWING STING THERAPY
Michael Monument
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Michael Monument
Favorite
Moon, Matthew

University of Iowa Hospitals and Clinics
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Matthew Moon
Favorite
Moore, Roxanne

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Roxanne Moore
Favorite
Moradkhani, Ania

Sarcoma Oncology Center
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Ania Moradkhani
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Ania Moradkhani
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Ania Moradkhani
Favorite
Morais, Alice

Instituto do Câncer do Estado de São Paulo
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Alice Morais
Favorite
Moral Duarte, Antonio

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Antonio Moral Duarte
Favorite
Morales, Samantha

University of South Carolina School of Medicine Greenville
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Samantha Morales
Favorite
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Samantha Morales
Favorite
Morelli, Daniele

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Daniele Morelli
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Daniele Morelli
Favorite
MORENO VEGA, ALBERTO

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
ALBERTO MORENO VEGA
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
ALBERTO MORENO VEGA
Favorite
Morey, Rohini

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Rohini Morey
Favorite
Moria, Feras

MUHC
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Feras Moria
Favorite
Morin, Niall

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Niall Morin
Favorite
Morita, Mitsunori

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Mitsunori Morita
Favorite
Morizane, Chigusa

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Chigusa Morizane
Favorite
Morosi, Carlo

Fondazione IRCCS Istituto nazionale dei tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Carlo Morosi
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Carlo Morosi
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Carlo Morosi
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Carlo Morosi
Favorite
Morris, Ashlyn

Indiana University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Ashlyn Morris
Favorite
Morris, Carol

Memorial Sloan Kettering Cancer Center
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Carol Morris
Favorite
Morris, Luc

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Luc Morris
Favorite
Morrissy, Sorana

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Sorana Morrissy
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Sorana Morrissy
Favorite
Moschetta, Ileana

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Ileana Moschetta
Favorite
Mosher, Hannah

University of Miami Miller School of Medicine
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Hannah Mosher
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Hannah Mosher
Favorite
Moskaluk, Christopher

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Christopher Moskaluk
Favorite
Mosu, Alexis

Visgauss Lab — Duke Orthopedic Oncology
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Alexis Mosu
Favorite
Mottard, Sophie

Maisonneuve-Rosemont Hospital
(P 46) INVESTIGATING THE IMPACT OF SARCOMA FUSION PROTEINS ON EPIGENETIC AND DNA-DEPENDENT PROCESSES THROUGH INTERACTOME PROFILING
Sophie Mottard
Favorite
Movva, Sujana

Memorial Sloan Kettering Cancer Center
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Sujana Movva
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Sujana Movva
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Sujana Movva
Favorite
Mridha, Asit

AIIMS Delhi
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Asit Mridha
Favorite
Mukarrama, Trasneem

Biomedical Engineering, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Trasneem Mukarrama
Favorite
Mukherjee, Elina

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Elina Mukherjee
Favorite
Mullinax, John

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
John Mullinax
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
John Mullinax
Favorite
Mundra, Piyush

Children's Cancer Institute of Australia
(P 49) GENETIC INTERACTION BETWEEN SPRED3 AND SMARCB1 CAUSES EXPLOSIVE MULTIFOCAL MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Piyush Mundra
Favorite
Munnangi, Pujita

University of California, San Francisco
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Pujita Munnangi
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Pujita Munnangi
Favorite
Muramatsu, Shudai

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Shudai Muramatsu
Favorite
Murata, Hideki

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Hideki Murata
Favorite
Murphy Jr., William A.

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
William A. Murphy Jr.
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
William A. Murphy Jr.
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
William A. Murphy Jr.
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
William A. Murphy Jr.
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
William A. Murphy Jr.
Favorite
Murphy, Erin

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Erin Murphy
Favorite
Murphy, Mary

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Mary Murphy
Favorite
Murphy, William

Department of Dermatology, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
William Murphy
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
William Murphy
Favorite
Murray, Hazel

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Hazel Murray
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Hazel Murray
Favorite
Murray, Michael

Rush University Medical Center
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Michael Murray
Favorite
Murugesan, Manikandan

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Manikandan Murugesan
Favorite
Musselman, Madelaine

Ohio State University
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Madelaine Musselman
Favorite
Mutter, Robert

Mayo Clinic
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Robert Mutter
Favorite
Myers, Sara

The James Cancer Hospital - The Ohio State University Comprehensive Cancer Center
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Sara Myers
Favorite
Myklebost, Ola

Oslo University Hospital
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Ola Myklebost
Favorite